Conclusions
DPK is a research tool that has not been validated or shown to be correlated to clinical efficacy and systemic safety
PhRMA wishes to participate on any Expert Panel or committee for this topic that is established by the Advisory Committee for Pharmaceutical Science or Dermatology and Ophthalmic Advisory Committee.